NM_005194.4:c.317C>A

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_005194.4(CEBPB):​c.317C>A​(p.Pro106His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000282 in 1,454,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000028 ( 0 hom. )

Consequence

CEBPB
NM_005194.4 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.04
Variant links:
Genes affected
CEBPB (HGNC:1834): (CCAAT enhancer binding protein beta) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions. [provided by RefSeq, Oct 2013]
CEBPB-AS1 (HGNC:51226): (CEBPB antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.122484446).
BS2
High AC in GnomAdExome4 at 37 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEBPBNM_005194.4 linkc.317C>A p.Pro106His missense_variant Exon 1 of 1 ENST00000303004.5 NP_005185.2 P17676-1
CEBPBNM_001285878.1 linkc.248C>A p.Pro83His missense_variant Exon 1 of 1 NP_001272807.1 P17676-2
CEBPBNM_001285879.1 linkc.-278C>A 5_prime_UTR_variant Exon 1 of 1 NP_001272808.1 P17676-3
CEBPB-AS1NR_125739.1 linkn.479G>T non_coding_transcript_exon_variant Exon 2 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEBPBENST00000303004.5 linkc.317C>A p.Pro106His missense_variant Exon 1 of 1 6 NM_005194.4 ENSP00000305422.3 P17676-1
CEBPB-AS1ENST00000613921.1 linkn.149G>T non_coding_transcript_exon_variant Exon 1 of 6 3

Frequencies

GnomAD3 genomes
AF:
0.0000266
AC:
4
AN:
150552
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.000483
GnomAD4 exome
AF:
0.0000284
AC:
37
AN:
1304298
Hom.:
0
Cov.:
31
AF XY:
0.0000311
AC XY:
20
AN XY:
643472
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000414
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000233
Gnomad4 OTH exome
AF:
0.0000764
GnomAD4 genome
AF:
0.0000266
AC:
4
AN:
150658
Hom.:
0
Cov.:
33
AF XY:
0.0000272
AC XY:
2
AN XY:
73592
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000148
Gnomad4 OTH
AF:
0.000478
Bravo
AF:
0.0000189
ExAC
AF:
0.0000109
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 04, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.317C>A (p.P106H) alteration is located in exon 1 (coding exon 1) of the CEBPB gene. This alteration results from a C to A substitution at nucleotide position 317, causing the proline (P) at amino acid position 106 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
23
DANN
Benign
0.84
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.75
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.41
T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.40
N
REVEL
Benign
0.011
Sift
Benign
0.60
T
Sift4G
Benign
0.22
T
Polyphen
0.40
B
Vest4
0.27
MutPred
0.25
Loss of glycosylation at P106 (P = 0.0057);
MVP
0.16
MPC
2.0
ClinPred
0.12
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.4
Varity_R
0.13
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs747170675; hg19: chr20-48807887; API